Updated:
DEFTA Partners
DEFTA Partners invests in early-stage healthcare, biotechnology, and ICT companies in the US and internationally. The firm focuses on growth and expansion of...
DEFTA Partners
DEFTA Partners invests in early-stage healthcare, biotechnology, and ICT companies in the US and internationally. The firm focuses on growth and expansion of its portfolio companies. Founded in 1985 in San Francisco, California, DEFTA Partners has made 46 investments and had 6 portfolio exits.
General information
Firm type
Private Equity
Year founded
1980
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
111 Pine Street, Suite 1410, San Francisco, CA 94111, USA
Additional offices
Yokohama, Japan
Principals
George Hara
Group Chairman & CEO
Satoshi Tsubotani
General Manager of Business Development, DEFTA Capital
Takeo Sako
Deputy General Manager of Business Development, DEFTA Capital
Kyoko Watanabe
Managing Director, DEFTA Corporation
Baldev Madahar
CFO, DEFTA Corporation
Masahide Isono
Principal, DEFTA Corporation
Susumu Kaminaga
Board Director, DEFTA Capital
Mikio Tanji
Executive Officer, DEFTA Capital
May Takahashi
Investment & Business Development Manager, DEFTA Corporation
Yoshiko Kumachi-Takaike
Director of the Board, DEFTA Capital
Yoshiyuki Katsuragi
Director of Business Development, DEFTA Capital
Sector focus
Frequently asked questions
Who runs investment decisions at DEFTA Partners?
George Hara, as Group Chairman & CEO, leads the firm's overall investment direction and strategy. The investment and business development functions are managed by a team that includes Satoshi Tsubotani (General Manager), Takeo Sako (Deputy General Manager), and Masahide Isono (Principal), operating from both the San Francisco and Yokohama offices. The firm does not publicly detail investment committee structure or voting protocols.
How does DEFTA Partners source its deal flow?
DEFTA's sourcing model relies on George Hara's long-standing networks in technology and government, particularly in Japan and the US. The firm's dual presence in Silicon Valley and Yokohama provides access to both Western innovation clusters and Asian corporate partnerships. Its unusual relationship with BRAC in Bangladesh also creates proprietary infrastructure and tech-enabled service opportunities that most venture firms never see.
Which sectors does DEFTA Partners explicitly avoid?
DEFTA's public statements do not list explicitly excluded sectors. The stated focus is on information and communication technology, biotechnology, pharmaceuticals, and healthcare, with a recent pivot toward advanced therapeutics and health IT. Sectors outside these domains — such as heavy industry, commodities, or consumer goods — appear absent from their portfolio, but no formal exclusion policy is disclosed.
Does DEFTA Partners participate in fund commitments or only direct deals?
The firm's public materials describe direct investments in over 100 companies, without mention of fund-of-funds commitments or LP positions in other venture firms. The bracNet joint venture in Bangladesh demonstrates a willingness to use operating-company and project-level structures, but evidence of fund investments in third-party managers is not publicly available.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: